Cover Image
市場調查報告書

Heat Biologics, Inc.:產品平台分析

Heat Biologics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 199698
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Heat Biologics, Inc.:產品平台分析 Heat Biologics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月09日 內容資訊: 英文 32 Pages
簡介

Heat Biologics, Inc.是開發針對各種癌症,病毒性疾病,自體免疫疾病的治療用技術之生物科技企業。

本報告提供Heat Biologics, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,後期階段及中止的計劃等相關資訊。

Heat Biologics, Inc.的基本資料

  • Heat Biologics, Inc.概要
  • 主要資訊
  • 企業資料

Heat Biologics, Inc.:R&D概要

  • 主要的治療範圍

Heat Biologics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Heat Biologics, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Heat Biologics, Inc.:藥物簡介

  • viagenpumatucel-L
  • HS-210
  • HS-310
  • HS-510
  • HS-HIV1
  • 癌症治療細胞療法

Heat Biologics, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Heat Biologics, Inc.:最近的開發平台趨勢

Heat Biologics, Inc.:暫停中的計劃

Heat Biologics, Inc.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07562CDB

Summary

Global Markets Direct's, 'Heat Biologics, Inc. - Product Pipeline Review - 2015', provides an overview of the Heat Biologics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Heat Biologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Heat Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Heat Biologics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Heat Biologics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Heat Biologics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Heat Biologics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Heat Biologics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Heat Biologics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Heat Biologics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Heat Biologics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Heat Biologics, Inc. Snapshot
    • Heat Biologics, Inc. Overview
    • Key Information
    • Key Facts
  • Heat Biologics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Heat Biologics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Heat Biologics, Inc. - Pipeline Products Glance
    • Heat Biologics, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Heat Biologics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Heat Biologics, Inc. - Drug Profiles
    • vesigenurtucel-L
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • viagenpumatucel-L
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HS-210
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HS-310
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HS-510
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HS-HIV1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cell Therapy for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Heat Biologics, Inc. - Pipeline Analysis
    • Heat Biologics, Inc. - Pipeline Products by Route of Administration
    • Heat Biologics, Inc. - Pipeline Products by Molecule Type
  • Heat Biologics, Inc. - Recent Pipeline Updates
  • Heat Biologics, Inc. - Dormant Projects
  • Heat Biologics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Heat Biologics, Inc., Key Information
  • Heat Biologics, Inc., Key Facts
  • Heat Biologics, Inc. - Pipeline by Indication, 2015
  • Heat Biologics, Inc. - Pipeline by Stage of Development, 2015
  • Heat Biologics, Inc. - Monotherapy Products in Pipeline, 2015
  • Heat Biologics, Inc. - Phase II, 2015
  • Heat Biologics, Inc. - Preclinical, 2015
  • Heat Biologics, Inc. - Discovery, 2015
  • Heat Biologics, Inc. - Pipeline by Route of Administration, 2015
  • Heat Biologics, Inc. - Pipeline by Molecule Type, 2015
  • Heat Biologics, Inc. - Recent Pipeline Updates, 2015
  • Heat Biologics, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Heat Biologics, Inc. - Pipeline by Top 10 Indication, 2015
  • Heat Biologics, Inc. - Pipeline by Stage of Development, 2015
  • Heat Biologics, Inc. - Monotherapy Products in Pipeline, 2015
  • Heat Biologics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Heat Biologics, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top